Gene · 51428
Papers1,824
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,824
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Germline DDX41 mutations in myeloid neoplasms: a comprehensive review. | Korean J Intern Med | 2026 | 42128380 | PubTator, text mining | PubMed |
| Genomic Determinants and Clinical Outcomes of Second Primary Hematological Malignancies in Patients with B-cell Cancers. | Transplant Cell Ther | 2026 | 42035873 | PubTator, text mining | PubMed |
| Germline DDX41 Variants: Current Understanding and Future Directions. | Curr Hematol Malig Rep | 2026 | 42024186 | PubTator, text mining | PubMed |
| Genetic characterization of AML defined by differentiation shows a high frequency of DDX41 mutations. | Br J Haematol | 2026 | 41979368 | PubTator, text mining | PubMed |
| Leveraging paired germline and somatic analysis to improve the classification of DDX41 variants. | Br J Haematol | 2026 | 41873058 | PubTator, text mining | PubMed |
| [Chinese guidelines for diagnosis and treatment of myelodysplastic neoplasms (2026)]. | Zhonghua Xue Ye Xue Za Zhi | 2026 | 41839623 | PubTator, text mining | PubMed |
| MDS/AML-associated DDX41 helicase facilitates homologous recombination repair by potentially resolving R-loops. | Nucleic Acids Res | 2026 | 41816910 | PubTator, text mining | PubMed |
| Preliminary evidence for the integration of CNAs, CN-LOH and mutational profiles into the prognostic stratification of elderly patients with NPM1-mutated acute myeloid leukemia. | Oncol Lett | 2026 | 41797886 | PubTator, text mining | PubMed |
| Correlation between carbon percentage and nanocomposite performance in commodity and engineering thermoplastics (ABS, HIPS, PP, and PC). | Sci Rep | 2026 | 41792209 | PubTator, text mining | PubMed |
| Association of Aβ monomers with cerebral amyloid angiopathy in brains without parenchymal Aβ deposition. | Brain Commun | 2026 | 41783833 | PubTator, text mining | PubMed |
| Single vs dual genetic disease in children with congenital anomalies and solid tumors. | Genet Med Open | 2026 | 41783072 | PubTator, text mining | PubMed |
Somatic and germline genetic testing pathways in haematological malignancies: Best practice consensus guidelines from the 2025 national meeting organised by UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group. | Br J Haematol | 2026 | 41773566 | PubTator, text mining | PubMed |
| CRISPR/Cas9 screening with destabilized bicistronic fluorescent protein reporter revealed PABPN1 as a hub of regulators for alternative polyadenylation. | Nucleic Acids Res | 2026 | 41755634 | PubTator, text mining | PubMed |
| Venezuelan Equine Encephalitis Virus Antagonizes the cGAS-STING Pathway. | Cells | 2026 | 41744770 | PubTator, text mining | PubMed |
| Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib. | Ann Hematol | 2026 | 41729290 | PubTator, text mining | PubMed |
| Regulation of transcription by R loop-nucleated transcription condensate assembly. | Cell Biosci | 2026 | 41703613 | PubTator, text mining | PubMed |
| Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets. | Leukemia | 2026 | 41703027 | PubTator, text mining | PubMed |
| Pathogenic Role of FGFR3 Autoantibodies in Small Fiber Neuropathy. | Adv Sci (Weinh) | 2026 | 41700748 | PubTator, text mining | PubMed |
| Re-treatment of relapse in elderly AML with time-limited venetoclax-based regimen: a case report and literature review. | Ann Hematol | 2026 | 41699187 | PubTator, text mining | PubMed |
| DDX41 facilitates PD-L1-mediated immune escape in OSCC via the phase separation and activation STING pathway. | NPJ Precis Oncol | 2026 | 41673322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51428/papers?page=2